NCT04692285 - Electrophysiological and Neuroimaging Correlates of the Effect of Zolpidem in Patients With Focal Dystonia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2017

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions

Focal Dystonia

Interventions

DRUG

Zolpidem

Patients will undergo transcranial magnetic stimulation, 18F-FDG-PET brain imaging, and clinical testing after a single 5 mg dose of Zolpidem.

DRUG

Placebo

Patients will undergo transcranial magnetic stimulation, 18F-FDG-PET brain imaging, and clinical testing after a single dose of placebo.

Trial Locations (2)

Departmet of Neurology, University Medical Centre Ljubljana, Ljubljana

University Clinical Centre of Serbia, Belgrade